We are MAP Pharmaceuticals
A New Direction in Medicine
MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients’ hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals’ goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.
Current development programs in neurology at MAP Pharmaceuticals include proprietary product candidates that address large market opportunities, including migraine. Our most advanced product candidate is LEVADEX®, an orally inhaled investigational drug for the acute treatment of migraine in adults.